ima and quantum yields, indicating that the dansyl group in two of them was engaged in intramolecular hydrophobic interactions. These dansylated [Dmt 1 ]DALDA analogues represent valuable tools for binding studies, cellular uptake and intracellular distribution studies, and tissue distribution studies.
The dermorphin tetrapeptide analogue [Dmt 1 ]DALDA (H-Dmt-D-Arg-Phe-Lys-NH 2 ; Dmt = 2¢,6¢-dimethyltyrosine) is a highly potent and selective m opioid peptide agonist capable of producing a long-lasting antinociceptive effect (Schiller et al., 2000; Zhao et al., 2002) . Furthermore, this peptide has been shown to be internalized into CACO-2 cells by a mechanism which does not involve receptor-mediated endocytosis (Zhao et al., 2003) . This internalization was visualized in a confocal laser fluorescence microscopy study using the fluorescent analogue [Dmt 1 ,Dap(dns
. This dansylated peptide analogue retained subnanomolar m opioid receptor binding affinity, very high m opioid agonist activity in the guinea pig ileum (GPI) assay and extraordinarily high antinociceptive activity in the mouse tail-flick test (intrathecal administration) (Berezowska et al., 2003) with those of the N-acetylated and carboxamidated reference amino-acid N-Ac-Dap(dns)-NH 2 , in which the fluorophore is completely exposed to the water. The fluorescent peptide showed the same fluorescence emission maximum (l max em = 578 nm) as N-Ac-Dap(dns)-NH 2 and a similar fluorescence quantum yield (Table 3), indicating that its dansyl group is completely exposed to the aqueous environment and is not involved in any intramolecular interactions with peptide moieties that would affect the quantum yield and the location of the fluorescence emission maximum.
In O (15:10:3:12) . Preparative reversed-phase HPLC was performed on a Vydac 218-TP1022 column (22´250 mm) with a linear gradient of 5-22% (first 20 min) and 22-30% (next 20 min) acetonitrile in 0.1% TFA at a flow rate of 13 mL/min. Analytical reversed-phase HPLC was performed on a Vydac 218TP54 column (5´250 mm) with a linear gradient of 5-30% acetonitrile in 0.1% TFA over 30 min at a flow rate of 1.5 mL/min. The same column was also used for the determination of the capacity factors K' under isocratic conditions (20% acetonitrile in 0.1% TFA). Molecular masses of compounds were determined by FAB mass spectrometry on an MS-50 HMTCTA mass spectrometer interfaced to a DS-90 data system (Dr. M. Evans, Department of Chemistry, University of Montreal).
Peptide synthesis: H-Dmt-D-Arg-PheLys(dns)-NH 2 . All reactions were carried out in the dark to prevent photodegradation of the dansyl group. The peptide was synthesized by the manual solid-phase technique using Boc-protection for the a-amino group, except for Dmt, which was Fmoc-protected. Side chain protection was as follows: tosyl (Arg), dansyl (Lys). Boc-Lys(dns)-OH was synthesized in a manner analogous to that reported for the preparation of Z-Lys(dns)-OH (Schwyzer et al., 1971) . 1,3-Diisopropylcarbodiimide (DIC)/1-hydroxybenzotriazole (HOBt) were used as coupling agents. The peptide was assembled on a p-methylbenzhydrylamine resin according to a published protocol (Schiller et al., 2000) . After peptide assembly was complete, Fmoc protection was removed with 30% (v/v) piperidine in dimethyl formamide (DMF) and the peptide was cleaved from the resin by HF/anisole treatment in the usual manner. The crude peptide was purified by preparative reversed-phase HPLC and was found to be at least 98% pure, as assessed by TLC and HPLC. TLC R f 0.20 (I), 0.78 (II); K' 1.28; FAB-MS m/e 873.
Peptide synthesis: H-Dmt-D-Arg-PheLys-NH-(CH 2 ) 2 -NH-dns. For the preparation of TFA´H 2 N-(CH 2 ) 2 -NH-dns, NaHCO 3 (0.318 g, 3 mM) was added to a solution of N-Boc-ethylenediamine (0.256 mL, 1.62 nM) in water (5 mL), followed by addition of dansyl chloride (0.545 g, 2.02 mM) in acetone (10 mL) at room temp. After 2 h, the acetone was evaporated in vacuo, and ethyl acetate and aq. NaCl (sat.) were added. The ethyl acetate extract was dried over MgSO 4 , filtered and evaporated to yield Boc-NH-(CH 2 ) 2 -NHdns as a yellow solid. N-Boc protection was removed by TFA treatment (30 min at 0°C) and after TFA evaporation, TFA´H 2 N-(CH 2 ) 2 -NH-dns was obtained in the form of yellow crystals. The peptide was assembled in solution using the symmetrical anhydride method and N a -Fmoc protection. Side chain protection was as follows: Pmc (Arg), Boc (Lys Pharmacological testing in vitro. The guinea pig ileum (GPI) and mouse vas deferens (MVD) bioassays were carried out as reported in detail elsewhere (Schiller et al., 1978; DiMaio et al., 1982) . A dose-response curve was determined with [Leu 5 ]enkephalin as standard for each ileum and vas preparation, and IC 50 values of the compounds being tested were normalized according to a published procedure (Waterfield et al., 1979) . Opioid receptor binding studies were performed as described in detail elsewhere (Schiller et al., 1978 Fluorescence spectroscopy. Fluorescence emission spectra were recorded on a SLMAminco SPF-500C spectrofluorometer with 2 nm spectral resolution for excitation and emission. Solutions of peptides and reference amino acids in Tris/HCl buffer (pH 6.6) at a concentration of 2´10 -5 M were used. The excitation wavelength was 350 nm. Fluorescence quantum yields (j) were determined relative to N-acetyl-L-tryptophanamide (NA-TA) (j NATA = 0.14) as reference. The quantum yield was calculated based on the following equation:
where the subscripts S and R refer to the sample and reference compound (NATA), respectively. E is the integrated area under the corrected emission spectrum. A is the absorbance of the solution at the excitation wavelength (A < 0.05) and (n S /n R ) 2 is the correction for the refractive index.
RESULTS AND DISCUSSION
As was reported previously (Berezowska et al., 2003) analogues is only 2+ at physiological pH. As observed in an earlier study, gradual augmentation of the positive charge from 1+ to 3+ in a series of dermorphin-(1-4) tetrapeptide analogues produced a progressive increase in m receptor selectivity (Schiller et al., 1989) . The fluorescence emission maximum of the dansyl group is known to be strongly dependent on the polarity of its environment. While the emission maximum of N e -dansyllysine and of N b -dansyl-L-a,b-diaminopropionic acid or its N-acetylated and carboxamidated derivative (Ac-Dap(dns)-NH 2 ) is at 578 nm (Schiller et al., 1972; Berezowska et al., 2003) , a hypsochromic shift of up to 80 nm is observed with the dansyl fluorophore in lipophilic sur-roundings (Chen, 1967; Parker et al., 1967 tide conformers in which the fluorophore is located in a somewhat hydrophobic environment. This is also indicated by the 50% increase of the dansyl fluorescence quantum yield seen with this peptide (j = 0.45) as compared to the reference amino-acid Ac-Dap-(dns)-NH 2 (j = 0.30). Obviously, the long, flexible side chain of the dansylated lysine residue permits interactions with one or several lipophilic moieties in the peptide. In contrast, the shortness of the dansylated side chain of the N b -dansyl-a,b-diaminopropionic acid residue in H-Dmt-D-Arg-Phe-Dap(dns)-NH 2 does not permit such interactions. With the C-terminally dansylated analogue H-Dmt-D-ArgPhe-Lys-NH-(CH 2 ) 2 -NH-dns a slightly smaller hypsochromic shift (6 nm) in the dansyl fluorescence emission maximum and a smaller (20%) increase in the fluorescence quantum yield (j = 0.036) are observed (Table 3) . These fluorescence parameters indicate that the dansyl group in this peptide is also involved in intramolecular hydrophobic interactions with lipophilic moieties, but to a lesser degree than it is the case with the dansyl group in H-Dmt-D-Arg-Phe-Lys(dns)-NH 2 .
In conclusion, we prepared three highly potent, dansylated analogues of the m opioid peptide agonist [Dmt 1 ]DALDA. One of these analogues, H-Dmt-D-Arg-Phe-Lys-NH-(CH 2 ) 2 -NH-dns displayed improved m vs. d receptor selectivity as compared to the other two which were relatively non-selective. Two of the analogues showed blue-shifts of the dansyl fluorescence emission maximum and increases in the fluorescence quantum yield. These findings represent the first evidence to indicate that fluorophores contained even in small peptides may engage in significant intramolecular interactions with lipophilic moieties. These dansylated [Dmt 1 ]DALDA analogues are expected to be useful as pharmacological tools for various applications, including binding studies with receptors and other biopolymers, cellular uptake and intracellular distribution studies by confocal laser scanning microscopy and tissue distribution studies.
